Guess?, Inc. ( GES ) reported its fourth-quarter financial results after the bell Thursday. Here's a look at the highlights. The Details: Guess? reported quarterly earnings of $2.01 per share which beat the analyst consensus estimate of $1.56 by 28.85%. Quarterly sales clocked in at $891.05 million, beating the analyst consensus estimate of $855.54 million by 4.15% and representing an...

04:45 PM EDT, 03/20/2024 (MT Newswires) -- Alvotech ( ALVO ) reported a full-year 2023 loss late Wednesday of $2.43 per diluted share, narrower than a loss of $2.60 a year earlier. Four analysts surveyed by Capital IQ expected a loss of $1.09. Revenue for the year ended Dec. 31 was $93.4 million, up 10% from a year earlier. Analysts...

04:44 PM EDT, 03/20/2024 (MT Newswires) -- Fusion Pharmaceuticals ( FUSN ) late Wednesday reported a Q4 net loss of $0.39 per diluted share, compared with a $0.55 loss a year earlier. Analysts polled by Capital IQ expected a loss of $0.33. The company did not report any revenue for the quarter ended Dec. 31 compared with $140,000 a year...

04:42 PM EDT, 03/20/2024 (MT Newswires) -- Myriad Genetics ( MYGN ) said late Wednesday the US Patent and Trademark Office granted it a patent covering the use of its blood-collection devices to determine fetal sex. The patent protects the company's SneakPeek Snap products in the country through at least 2040, Myriad said, and it also covers technology to improve...